People

Along with other companies, 5AM Ventures (which Scott M. Rocklage is a founding and managing partner of), has been helping finance Expansion Therapeutics’ Series A financing for fighting genetic disorders, such as myotonic dystrophy type 1, the leading cause of muscular dystrophy in adults. Expansion Therapeutics focuses on creating medications that intervene in illnesses that
Read More

Scott Rocklage joined 5AM Ventures in 2003 and became the company’s Managing Partner just a year later. Before he was put into this position at the company, he worked at several healthcare companies, including Cubist Pharmaceuticals, where he served as Chairman and CEO from 1994 to 2003. In his more than 3 decades of experience
Read More